Cancer Immunology Research impact factor, indexing, ranking (2024)


cancer

Aim and Scope

The Cancer Immunology Research is a research journal that publishes research related to Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology. This journal is published by the American Association for Cancer Research Inc.. The ISSN of this journal is 23266066, 23266074. Based on the Scopus data, the SCImago Journal Rank (SJR) of cancer immunology research is 3.552.

Also, please check the following important details about cancer immunology research: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Cancer Immunology Research Ranking

Impact Factor: 8.1
5-Year JIF: 10.1
SJR (SCImago Journal Rank): 3.552
Quartile: Q1

The latest Impact Factor list (JCR) is released in June 2024.

The Impact Factor of Cancer Immunology Research is 8.1.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: Cancer Immunology Research
Publisher: American Association for Cancer Research Inc.
ISSN: 23266066, 23266074
Type: journal
Journal Scope: Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology
Country: United States
H-Index: 116
SJR: 3.552
Quartile: Cancer Research (Q1); Immunology (Q1)

Indexing

The cancer immunology research is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Cancer Immunology Research Impact Factor 2024

The latest impact factor of cancer immunology research is 8.1 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Quartile

The latest Quartile of cancer immunology research is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Cancer Immunology Research?

If your research is related to Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology, then visit the official website of cancer immunology research and send your manuscript.

Tips for publishing in Cancer Immunology Research:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of cancer immunology research is 8.1.
  • The cancer immunology research is a reputed research journal.
  • It is published by American Association for Cancer Research Inc..
  • The journal is indexed in UGC CARE, Scopus, SCIE, PubMed.
  • The (SJR) SCImago Journal Rank is 3.552.

Sources: cancer immunology research







SIMILIAR JOURNALS


INNATE IMMUNITY

ISSN: 1753-4259
Publisher: SAGE PUBLICATIONS LTD

GENES & GENOMICS

ISSN: 1976-9571
Publisher: SPRINGER

GENE THERAPY

ISSN: 0969-7128
Publisher: SPRINGERNATURE

GENOME RESEARCH

ISSN: 1088-9051
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT

INTERNATIONAL JOURNAL OF GENOMICS

ISSN: 2314-436X
Publisher: HINDAWI LTD

MAMMALIAN GENOME

ISSN: 0938-8990
Publisher: SPRINGER

YEAST

ISSN: 0749-503X
Publisher: WILEY

CYTOKINE

ISSN: 1043-4666
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD

EUROPEAN CYTOKINE NETWORK

ISSN:
Publisher: JOHN LIBBEY EUROTEXT LTD

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

ISSN: 1079-9907
Publisher: MARY ANN LIEBERT, INC

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.